The Legal Intelligencer | News
By Max Mitchell | August 23, 2019
Judge Kenneth Powell filed an opinion earlier this week contending that defendant Ethicon's numerous issues on appeal are "meritless," and asking the appellate court to affirm the verdict in Emmet v. Ethicon.
The Legal Intelligencer | Commentary
By Angus Love | August 16, 2019
The question is whether we should allow such a site in Kensington, ground zero of the opioid crisis. The site would allow addicts to come with their drugs into a clinical setting and use clean needles, have opioid antidotes available and treatment options for the users.
The Legal Intelligencer | News
By Max Mitchell | August 9, 2019
U.S. District Judge J. Curtis Joyner of the Eastern District of Pennsylvania granted a motion to quash a subpoena issued by Retrophin, in which the company sought to depose an executive at Prinston Pharmaceuticals.
The Legal Intelligencer | News
By Kristen Rasmussen | August 7, 2019
Neena Patil, who held in-house roles at Novo Nordisk and Pfizer Inc., has become general counsel at Jazz Pharmaceuticals Inc.
The Legal Intelligencer | News
By P.J. D'Annunzio | August 5, 2019
The Pennsylvania Supreme Court has declined to hear a Johnson & Johnson subsidiary's appeal in the first Risperdal lawsuit in Philadelphia to result in a plaintiff's verdict.
The Legal Intelligencer | News
By Max Mitchell | July 17, 2019
A unanimous three-judge panel of the Pennsylvania Superior Court on Tuesday reversed an order that granted a motion for nonsuit in the case T.M. v. Janssen Pharmaceuticals, and remanded the case to the Philadelphia Court of Common Pleas for a new trial.
The Legal Intelligencer | Commentary
By Joshua Horn and Ellis W. Martin | June 25, 2019
While the president and Congress gave hemp the go-ahead, it is now on the regulators to take the next step. The FDA has authority to regulate cannabis-derived compounds, including CBD, under the Federal Food, Drug, and Cosmetic Act. So far, though, the FDA has not done much regulating in regards to CBD.
The Legal Intelligencer | News
By Max Mitchell | June 12, 2019
U.S. District Judge Mark Kearney of the Eastern District of Pennsylvania on Tuesday remanded the case to the Philadelphia Court of Common Pleas, denying arguments from the pharmaceutical giant that the case needed to be sent to bankruptcy court in Delaware.
The Legal Intelligencer | News
By Max Mitchell | June 3, 2019
Ethicon, a J&J subsidiary, had cited intense and allegedly incorrect media attention as the basis for its motion seeking to either have trials moved to a venue outside the five-county Philadelphia area, or have a “pretrial cooling off-period” before beginning the next trial.
The Legal Intelligencer | News
By P.J. D'Annunzio | May 30, 2019
A pharmaceutical company accused of illegally using benefits to entice physicians to prescribe its dermatology drugs has settled those claims with the federal government for $3.5 million, the U.S. Attorney's Office for the Eastern District of Pennsylvania has announced.
Presented by BigVoodoo
The Legal Intelligencer honors lawyers leaving a mark on the legal community in Pennsylvania and Delaware.
Consulting Magazine recognizes leaders in technology across three categories Leadership, Client Service and Innovation.
Celebrate outstanding achievement in law firms, chambers, in-house legal departments and alternative business structures.
We are seeking an associate to join our Employee Benefits practice. Candidates should have three to six years of employee benefits experienc...
Associate attorney position at NJ Immigration Law firm: Leschak & Associates, LLC, based in Freehold, NJ, is looking for a full time ass...
Duane Morris LLP has an immediate opening for a senior level, highly motivated litigation associate to join its dynamic and growing Employme...
MELICK & PORTER, LLP PROMOTES CONNECTICUT PARTNERS HOLLY ROGERS, STEVEN BANKS, and ALEXANDER AHRENS